Pentanedioic acid imidazolyl ethanamide clinical trials
Also written Ingavirin.
How each study uses pentanedioic acid imidazolyl ethanamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the pentanedioic acid imidazolyl ethanamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Valenta Pharm JSC (7) · Myelo Therapeutics GmbH (1)
Studies
Open first, then newest update. How each study uses pentanedioic acid imidazolyl ethanamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral InfectionsRecruitingPhase 4Valenta Pharm JSCNCT06315400Written as Ingavirin®
- Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19CompletedPhase 3Valenta Pharm JSCNCT05216497Written as Ingavirin®, 90 mg capsules
- Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced NeutropeniaCompletedPhase 2Myelo Therapeutics GmbHNCT02692742Written as Myelo001
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.CompletedPhase 3Valenta Pharm JSCNCT03206346Written as Ingavirin
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.CompletedPhase 3Valenta Pharm JSCNCT03191097Written as Ingavirin
- Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral InfectionsCompletedPhase 3Valenta Pharm JSCNCT03189537Written as Ingavirin (Imidazolyl Ethanamide Pentandioic Acid)
- Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in AdultsCompletedPhase 4Valenta Pharm JSCNCT03154515Written as Ingavirin
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.CompletedPhase 3Valenta Pharm JSCNCT02644018Written as Imidazolyl ethanamide pentandioic acid
As the comparator · 1 — what is tested is compared with pentanedioic acid imidazolyl ethanamide
Codes
What other systems call pentanedioic acid imidazolyl ethanamide · ClinicalTrials.gg INT005408
- MeSH (NLM) C539419pentanedioic acid imidazolyl ethanamideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3CM03MUJ69INGAVIRINConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C539419 | pentanedioic acid imidazolyl ethanamide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3CM03MUJ69 | INGAVIRIN | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.